2/10/2023 Impact of frailty on health care resource utilization and costs of care in myelodysplastic syndromes Mozessohn L, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Liu Y, Earle CC, Cheung MC, Mittmann N, Buckstein R. JCO Oncol Pract. 2023; Feb 10 [Epub ahead of print]. DOI: https://doi.org/10.1200/op.22.00668
6/1/2022 Frailty in patients with newly diagnosed diffuse large B-cell lymphoma receiving curative-intent therapy: a population-based study Vijenthira A, Mozessohn L, Nagamuthu C, Liu N, Blunt D, Alibhai S, Prica A, Cheung MC. J Natl Compr Canc Netw. 2022; 20(6):635-42. Epub 2022 Jun 1. DOI: https://doi.org/10.6004/jnccn.2022.7014
2/22/2022 The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes Brailovski E, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Liu Y, Earle CC, Cheung MC, Mittmann N, Buckstein RJ, Mozessohn L. Ann Hematol. 2022; 101(5):1023-30. Epub 2022 Feb 22. DOI: https://doi.org/10.1007/s00277-022-04802-1